snu387 cell lines (ATCC)
Structured Review

Snu387 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 308 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/snu387 cell lines/product/ATCC
Average 96 stars, based on 308 article reviews
Images
1) Product Images from "Synergistic role of riboflavin-auxotrophic Enterococcus for MR1 expression and intra-tumoral mucosal associated invariant T (MAIT) cell activation"
Article Title: Synergistic role of riboflavin-auxotrophic Enterococcus for MR1 expression and intra-tumoral mucosal associated invariant T (MAIT) cell activation
Journal: bioRxiv
doi: 10.1101/2025.11.25.690539
Figure Legend Snippet: A, J33-4 MAIT TCR recognition of U266 cells incubated overnight with (inverse black triangles) or without (black circles) 5-OP-RU, in presence or not of E.hirae , E. faecalis , E. faecium , E. coli and B. longum (Left graph) and E. avium (right graph, independent experiment). TCR activation is measured by bioluminescence reading. B , different APC (human dendritic cells, THP1, melanoma MeWO and hepatocellular carcinoma SNU387) were tested for the synergistic effect of E faecalis onto activation of conventional MAIT TCR J33-4 in presence (inverse black triangles) or not (black circles) of 5-OP-RU. C , Flow cytometry analysis of MR1 surface membrane expression using the 26.5 anti MR1 antibody staining of U266, THP1 and dendritic cells (DC) incubated overnight without or with 5-OP-RU in presence or not of E.faecalis . D , Inhibition by Ac-6-FP (escalating doses from 0.2 to 200 uM) of recognition by MAIT TCR J33-4 of MR1 expressed on U266 cultured or not with 5-OP-RU (6.25 uM) in presence (triangles) or not (squares) of E.faecalis (MOI:125). E , MAIT TCR J33-4 activation by Myd88 -/- THP1 cells incubated overnight with (inverse black triangles) or without (black circles) 5-OP-RU (6.25 uM), in presence or not of E. faecalis (MOI:125). F , MAIT TCR J33-4 activation by U266 cells incubated overnight with (inverse black triangles) or without (black circles) 5-OP-RU (6.25 uM), in presence or not of E. faecalis (MOI:125) and E.faecalis derived outer membrane vesicles (OMV). G , Flow cytometry analysis of MR1 surface membrane expression using the 26.5 anti MR1 antibody staining of U266 incubated overnight without or with 5-OP-RU in presence or not of E. faecalis (MOI:125), compared to LPS (TLR4 ligand; 50ng/ml; left histogram), CPG (TLR9 ligand; 5uM, middle histogram) or LTA (TLR2 ligand; 30ug/ml co; right histogram). All data are shown as mean ± SEM with technical replicates represented by number of symbols in each graph. ****:P<0.0001, ***:0.0001
Techniques Used: Incubation, Activation Assay, Flow Cytometry, Membrane, Expressing, Staining, Inhibition, Cell Culture, Derivative Assay, Two Tailed Test
![A Basal expression levels of miR-423-5p and MALAT-1 across seven HCC cell lines (SNU449, HepG2, SNU475, Hep3B, SKHep1, <t>SNU387,</t> and SNU389) assessed by qRT-PCR. Expression values were normalized to endogenous controls and used to guide selection of models for functional assays. B Generation of stable miR-423-5p-overexpressing clones in HepG2, Hep3B, and SNU387 cells using lentiviral vectors expressing GFP. Puromycin selection was applied to enrich successfully transduced cells. qRT-PCR confirmed persistent miR-423-5p upregulation. C Stable overexpression of miR-423-5p led to a consistent downregulation of MALAT-1 levels compared to vector-only controls in all three cell models. D – E Establishment of stable MALAT-1-overexpressing clones in SNU387 and Hep3B cells via lentiviral transduction. Overexpression was confirmed by qRT-PCR. In the selected clones (SNU387 clone 1 and Hep3B clone 2), MALAT-1 upregulation was associated with reduced miR-423-5p levels, confirming a reciprocal regulatory relationship. * \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$p < 0.05$$\end{document} p < 0.05 , ** p -value \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$< 0.01$$\end{document} < 0.01 , *** p -value \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$< 0.001$$\end{document} < 0.001 , **** p -value \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$< 0.0001$$\end{document} < 0.0001](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7375/pmc12487375/pmc12487375__13046_2025_3524_Fig2_HTML.jpg)
